Heart in diabetes: not only a macrovascular disease.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

25 citing papers in PubMed.

1. Asymptomatic coronary artery disease in a Norwegian cohort with type 2 diabetes: a prospective angiographic study with intravascular ultrasound evaluation.Cardiovascular diabetology · 2019
   Trial
2. Assessment of Knowledge on Cardiovascular Disease Risk Factors Among Diabetes Mellitus Patients in Tikur Anbessa Specialized Hospital, Ethiopia 2021: A Cross-Sectional Study.Nursing research and practice · 2025
   Article
3. Sex and Age Differences in the Impact of Metabolic Syndrome on Heart Failure Development.Metabolites · 2024
   Review
4. Interdependence between myocardial deformation and perfusion in patients with T2DM and HFpEF: a feature-tracking and stress perfusion CMR study.Cardiovascular diabetology · 2024
   Article
5. Emirates consensus recommendations on cardiovascular risk management in type 2 diabetes.Frontiers in endocrinology · 2024
   Review
6. Impact of glycemic control on biventricular function in patients with type 2 diabetes mellitus: a cardiac magnetic resonance tissue tracking study.Insights into imaging · 2023
   Article
7. Intravital assessment of precapillary pulmonary arterioles of type 1 diabetic mice shows oxidative damage and increased tone in response to NOS inhibition.Journal of applied physiology (Bethesda, Md. : 1985) · 2021
   Article
8. Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKα/TGF-β/Smad signalling in type 2 diabetic rats.Journal of cellular and molecular medicine · 2021
   Article
9. Cardioprotective Effect of Glycyrrhizin on Myocardial Remodeling in Diabetic Rats.Biomolecules · 2021
   Article
10. Diastolic function in patients with heart failure with preserved ejection fraction and atrial fibrillation: impact of diabetes.American journal of cardiovascular disease · 2021
    Article
11. Antioxidant Potential of Adiponectin and Full PPAR-PPAR research · 2021
    Article
12. Wild-Type Zebrafish (Animals : an open access journal from MDPI · 2020
    Review
13. Heart failure among people with Type 2 diabetes mellitus: real-world data of 289 954 people from a diabetes database.Diabetic medicine : a journal of the British Diabetic Association · 2020
    Article
14. Microvascular disease and heart failure with reduced and preserved ejection fraction in type 2 diabetes.ESC heart failure · 2020
    Article
15. Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy.Cardiovascular diabetology · 2020
    Article
16. The Relationship between Red Blood Cell Distribution Width and Incident Diabetes in Chinese Adults: A Cohort Study.Journal of diabetes research · 2020
    Article
17. Effect of Health Information Technologies on Cardiovascular Risk Factors among Patients with Diabetes.Current diabetes reports · 2019
    Review
18. "Heart failure, whole-body insulin resistance and myocardial insulin resistance: An intriguing puzzle".Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2018
    Article
19. Cardiovascular disease progression in female Zucker Diabetic Fatty rats occurs via unique mechanisms compared to males.Scientific reports · 2017
    Article
20. Red blood cell distribution width as a prognostic marker in patients with heart failure and diabetes mellitus.Cardiovascular diabetology · 2017
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as